Antifibrinolytic in subarachnoid hemorrhage

Neurosurgery

Volumn 69, Issue 2, 2011, Pages

  Thomas, Gaberel ^a   Evelyne, Emery ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; NIMODIPINE; TRANEXAMIC ACID;

BLEEDING; BRAIN ARTERY ANEURYSM; BRAIN INJURY; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; GLASGOW OUTCOME SCALE; HUMAN; LETTER; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TREATMENT OUTCOME;

6-AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENTS; BRAIN ISCHEMIA; FEMALE; HUMANS; HYDROCEPHALUS; MALE; SUBARACHNOID HEMORRHAGE;

EID: 79960357944     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31821ff91b     Document Type: Letter

References (9)

1. Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS III. Short-term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: Effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67(4):935-940.
2. Leipzig TJ, Redelman K, Horner TG. Reducing the risk of rebleeding before early aneurysm surgery: A possible role for antifibrinolytic therapy. J Neurosurg. 1997;86(2):220-225.
3. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: A prospective randomized study. J Neurosurg. 2002;97(4):771-778.
4. Starke RM, Kim GH, Fernandez A. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke. 2008; 39(9):2617-2621.
5. Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev. 2000;(2): CD001245.
6. Roos Y. Antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage: A randomized placebo controlled trial for the STAR-study group. Neurology. 2000;54(1):77-82.
7. Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms: A double-blind placebo-controlled study. Acta Neurochir (Wien). 1990;102 (1-2):1-10.
8. Vermeulen M, Lindsay KW, Murray GD, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311(7):432-437.
9. Review Manager (RevMan) [computer program]. Version 5.0. Copenhagen, Denmark: Nordic Cochrane Centre, Cochrane Collaboration; 2008.